Literature DB >> 18252013

Intralesional triamcinolone acetonide injection in hypertrophic skin surrounding the percutaneous titanium implant of a bone-anchored hearing aid.

J B Van Rijswijk1, E A M Mylanus.   

Abstract

OBJECTIVE: We present a patient with persistent hypertrophic skin surrounding the percutaneous implant of a bone-anchored hearing aid system, successfully treated with intralesional applied corticosteroids.
METHOD: Case report and review of the world literature concerning bone-anchored hearing aid implantation and intralesional applied corticosteroids for the treatment of hypertrophic scars and keloids.
RESULTS: Eight weeks after revision surgery to reduce surplus skin and subcutaneous scar tissue overgrowing the abutment, skin and subcutaneous scar tissue overgrowth reoccurred. As an alternative to yet another surgical procedure, the hypertrophic skin was treated with intralesional injections of triamcinolone acetonide. Three weeks after the treatment, a satisfying result was seen, and no subsequent relapse was observed.
CONCLUSION: To our knowledge, this is the first, photographically well documented case report of a patient with persistent hypertrophic skin surrounding a percutaneous bone-anchored hearing aid implant, successfully treated with intralesional applied corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252013     DOI: 10.1017/S0022215107001673

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Switching from a percutaneous to a transcutaneous bone anchored hearing system: the utility of the fascia temporalis superficialis pedicled flap in case of skin intolerance.

Authors:  A Devèze; S Rossetto; R Meller; M Sanjuan Puchol
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

2.  Skin reactions caused by bone-anchored hearing aid (BAHA) implantation.

Authors:  Gen-di Yin; Xiangli Zeng; Peng Li
Journal:  J Otol       Date:  2016-02-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.